Zarontin — Class III drug recall D-0002-2020
Terminated recall by Pfizer Inc., reported 2019-10-02, distributed nationwide. Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The lab
| Recall number | D-0002-2020 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pfizer Inc., New York, NY, United States |
| Recall initiated | 2019-09-12 |
| Classified | 2019-10-01 |
| Reported by FDA | 2019-10-02 |
| Terminated | 2023-04-10 |
| Distributed | Nationwide (US) |
| Reason classes | labeling |
| NDC | 00071-0237, 00071-0237-24 |
| Lot numbers | 3267079 |
| Expiration dates | 2021-09 |
Product
Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis Division of Pfizer In NY, NY 10017, NDC 0071-0237-24
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0002-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.